医保药品目录竞价准入与谈判准入的差异性分析

Analysis on the differences of bidding access and negotiation access of medical insurance catalog

竞价准入通道为我国首次提出的医保目录准入通道,目前仅具有初步的通道概念,具体操作流程尚不明晰。本文以国家医疗保障局第1号令--《基本医疗保险用药管理暂行办法》为依托,结合当前政策环境,分析了竞价准入通道的适用范围,并根据非独家品种的特点,从申报环节、遴选环节以及竞价环节对竞价准入与谈判准入的差异性进行了对比分析,旨在为我国竞价准入通道制度的完善提供参考。

Bidding access channel is the first access channel for medical insurance directory proposed in China.At present,this channel only has a preliminary concept,and the specific operation process is not clear yet.This paper,which was based on Decree No.1 of the National Healthcare Security Administration,Interim Measures for the Administration of Drugs for Basic Medical Insurance,combined with the current policy environment,analyzed the scope of bidding access channel.And according to the characteristics of drugs with generics available,the difference between bidding access and negotiation access was compared and analyzed from the link of declaration,selection and bidding,so as to provide reference for the system perfection of bidding access channel in China.